A clinical-grade constitutive packaging cell line for the production of self-inactivating lentiviral vectors

被引:0
|
作者
Knight, Sean [1 ,2 ]
Sanber, Khaled [1 ,2 ]
Stephen, Sam [1 ,2 ]
Ferraresso, Marta [1 ,2 ]
Baley, Ranbir [1 ,2 ]
Escors, David [1 ,2 ]
Santilli, Giorgia [3 ]
Thrasher, Adrian [3 ]
Collins, Mary [1 ,2 ]
Takeuchi, Yasu [1 ,2 ]
机构
[1] UCL, UCL Canc Inst, MRC UCL Ctr Med Mol Virol, London, England
[2] UCL, UCL Canc Inst, Wohl Virion Ctr, Div Infect & Immun, London, England
[3] UCL, Inst Child Hlth, Mol Immunol Unit, Ctr Immunodeficiency, London, England
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P142
引用
收藏
页码:A101 / A102
页数:2
相关论文
共 50 条
  • [21] The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo
    Park, F
    Ohashi, K
    Kay, MA
    MOLECULAR THERAPY, 2003, 8 (02) : 314 - 323
  • [22] Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors
    Schambach, Axel
    Galla, Melanie
    Maetzig, Tobias
    Loew, Rainer
    Baum, Christopher
    MOLECULAR THERAPY, 2007, 15 (06) : 1167 - 1173
  • [23] Long-term stability of clinical-grade lentiviral vectors for cell therapy
    Jadlowsky, Julie K.
    Leskowitz, Rachel
    Mckenna, Stephen
    Karar, Jayashree
    Ma, Yujie
    Dai, Anlan
    Plesa, Gabriela
    Chen, Fang
    Alexander, Kathleen
    Petrella, Jennifer
    Gong, Nan
    Hwang, Wei -Ting
    Farrelly, Olivia
    Barber-Rotenberg, Julie
    Christensen, Shannon
    Gonzalez, Vanessa E.
    Chew, Anne
    Fraietta, Joseph A.
    June, Carl H.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (01)
  • [24] Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors
    Diana E Jaalouk
    Milena Crosato
    Pnina Brodt
    Jacques Galipeau
    Virology Journal, 3
  • [25] Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors
    Jaalouk, Diana E.
    Crosato, Milena
    Brodt, Pnina
    Galipeau, Jacques
    VIROLOGY JOURNAL, 2006, 3 (1)
  • [26] Manufacture of clinical-grade lentiviral vectors for ex vivo use
    Gasmi, Anne Galyand Mehdi
    HUMAN GENE THERAPY, 2011, 22 (10) : A16 - A16
  • [27] Manufacture of Clinical-Grade Lentiviral Vectors for Ex Vivo Use
    Galy, Anne
    Galene, Emmanuel
    Than-Hoa Le
    Merten, Otto
    Barnay-Toutain, Frederic
    Charrier, Sabine
    Gasmi, Mehdi
    MOLECULAR THERAPY, 2012, 20 : S222 - S222
  • [28] To Develop a Lentiviral Packaging Cell Line for Scale-Up Production of Lentiviral Vectors
    Thomas, Amelia H.
    Slauson, Sarah
    Seidel, Stacie
    Veres, Gabor
    Ryu, Byoung Y.
    MOLECULAR THERAPY, 2014, 22 : S282 - S283
  • [29] Self-Inactivating Lentiviral Vectors for Correction of Rag1 Severe Combined Immunodeficiency
    Pike-Overzet, K.
    Rodijk, M.
    Ng, Y. Y.
    Baert, M. R. M.
    Lagresle-Peyrou, C.
    Schambach, A.
    Zhang, F.
    Hoeben, R. C.
    Hacein-Bey-Abina, S.
    Lankester, A. C.
    Bredius, R. G. M.
    Driessen, G. J. A.
    Thrasher, A. J.
    Baum, C.
    Cavazzana-Calvo, M.
    van Dongen, J. J. M.
    Staal, F. J. T.
    HUMAN GENE THERAPY, 2012, 23 (10) : A42 - A42
  • [30] Self-Inactivating Lentiviral Vectors for Correction of Rag1 Severe Combined Immunodeficiency
    Pike-Overzet, Karin
    Wiekmeijer, Anna-Sophia
    Baert, Miranda R. M.
    Lagresle-Peyrou, Chantal
    Schambach, Axel
    Zhang, Fang
    Hoeben, Rob C.
    Hacein-Bey-Abina, Salima
    Lankester, Arjen C.
    Bredius, Robbert G. M.
    Driessen, Gertjan J. A.
    Thrasher, Adrian J.
    Baum, Christopher
    Cavazzana-Calvo, Marina
    van Dongen, Jacques J. M.
    Staal, Frank J. T.
    MOLECULAR THERAPY, 2013, 21 : S120 - S121